tiprankstipranks
Dianthus Therapeutics (DNTH)
NASDAQ:DNTH
Holding DNTH?
Track your performance easily

Dianthus Therapeutics (DNTH) Financial Statements

305 Followers

Dianthus Therapeutics Financial Overview

Dianthus Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.498; its P/E ratio is -9.53; Dianthus Therapeutics is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.85. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue--$ 874.00K$ 1.43M$ 924.00K
Gross Profit----$ 924.00K
EBIT$ -25.17M$ -17.61M$ -17.84M$ -12.96M$ -15.76M
EBITDA$ -25.06M$ -16.98M$ -17.74M$ -12.85M$ -15.76M
Net Income Common Stockholders$ -25.17M$ -19.47M$ -13.75M$ -18.42M$ -14.76M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 281.12M$ 360.71M$ 377.04M$ 173.72M$ 189.87M
Total Assets$ 354.25M$ 368.96M$ 382.46M$ 179.41M$ 192.46M
Total Debt$ 311.00K$ 407.00K$ 497.00K$ 585.00K$ 670.00K
Net Debt$ -280.81M$ -360.30M$ -376.54M$ -173.13M$ -189.20M
Total Liabilities$ 16.35M$ 10.74M$ 9.78M$ 10.54M$ 14.08M
Stockholders Equity$ 337.90M$ 358.22M$ 372.69M$ 168.87M$ 178.38M
Cash Flow-
Free Cash Flow$ -21.29M$ -14.54M$ -14.97M$ -11.86M$ 11.90M
Operating Cash Flow$ -21.27M$ -14.53M$ -14.94M$ -11.85M$ 17.14M
Investing Cash Flow$ -259.36M$ 1.17M$ -5.51M$ -8.24M$ -16.88M
Financing Cash Flow$ 296.00K$ -2.20M$ 217.85M$ -4.87M$ 138.44M
Currency in USD

Dianthus Therapeutics Earnings and Revenue History

Dianthus Therapeutics Debt to Assets

Dianthus Therapeutics Cash Flow

Dianthus Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis